Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City

다국어 초록 (Multilingual Abstract)

Background: Data regarding the association between preexisting cardiovascular risk factors (CVRFs) and cardiovascular diseases (CVDs) and the outcomes of patients requiring hospitalization for coronavirus disease 2019 (COVID-19) are limited. Therefore, the aim of this study was to investigate the impact of preexisting CVRFs or CVDs on the outcomes of patients with COVID-19 hospitalized in a Korean healthcare system.
Methods: Patients with COVID-19 admitted to 10 hospitals in Daegu Metropolitan City, Korea, were examined. All sequentially hospitalized patients between February 15, 2020, and April 24, 2020, were enrolled in this study. All patients were confirmed to have COVID-19 based on the positive results on the polymerase chain reaction testing of nasopharyngeal samples. Clinical outcomes during hospitalization, such as requiring intensive care and invasive mechanical ventilation (MV) and death, were evaluated. Moreover, data on baseline comorbidities such as a history of diabetes, hypertension, dyslipidemia, current smoking, heart failure, coronary artery disease, cerebrovascular accidents, and other chronic cardiac diseases were obtained.
Results: Of all the patients enrolled, 954 (42.0%) had preexisting CVRFs or CVDs. Among the CVRFs, the most common were hypertension (28.8%) and diabetes mellitus (17.0%). The prevalence rates of preexisting CVRFs or CVDs increased with age (P < 0.001). The number of patients requiring intensive care (P < 0.001) and invasive MV (P < 0.001) increased with age.
The in-hospital death rate increased with age (P < 0.001). Patients requiring intensive care (5.3% vs. 1.6%; P < 0.001) and invasive MV (4.3% vs. 1.7%; P < 0.001) were significantly greater in patients with preexisting CVRFs or CVDs. In-hospital mortality (12.9% vs. 3.1%; P < 0.001) was significantly higher in patients with preexisting CVRFs or CVDs. Among the CVRFs, diabetes mellitus and hypertension were associated with increased requirement of intensive care and invasive MV and in-hospital death. Among the known CVDs, coronary artery disease and congestive heart failure were associated with invasive MV and in-hospital death.
In multivariate analysis, preexisting CVRFs or CVDs (odds ratio [OR], 1.79; 95% confidence interval [CI], 1.07–3.01; P = 0.027) were independent predictors of in-hospital death after adjusting for confounding variables. Among individual preexisting CVRF or CVD components, diabetes mellitus (OR, 2.43; 95% CI, 1.51–3.90; P < 0.001) and congestive heart failure (OR, 2.43; 95% CI, 1.06–5.87; P = 0.049) were independent predictors of in-hospital death.
Conclusion: Based on the findings of this study, the patients with confirmed COVID-19 with preexisting CVRFs or CVDs had worse clinical outcomes. Caution is required in dealing with these patients at triage.

참고문헌 (Reference)

1 World Health Organization, "WHO Director- General's opening remarks at the media briefing on COVID-19- 11 March 2020"

2 Walls AC, "Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein" 181 (181): 281-292, 2020

3 Channappanavar R, "Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection" 198 (198): 4046-4053, 2017

4 Wu C, "Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China" 180 (180): 934-943, 2020

5 Li B, "Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China" 109 (109): 531-538, 2020

6 Richardson S, "Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area" 323 (323): 2052-2059, 2020

7 Libby P, "Inflammation, immunity, and infection in atherothrombosis : JACC review topic of the week" 72 (72): 2071-2081, 2018

8 Xiong TY, "Coronaviruses and the cardiovascular system : acute and long-term implications" 41 (41): 1798-1800, 2020

9 Ruan Q, "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China" 46 (46): 846-848, 2020

10 Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China" 395 (395): 497-506, 2020

11 Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study" 395 (395): 1054-1062, 2020

12 Fang Z, "Clinical characteristics of coronavirus pneumonia 2019 (COVID-19): an updated systematic review"

13 Guan WJ, "Clinical characteristics of coronavirus disease 2019in China" 382 (382): 1708-1720, 2020

14 Wang D, "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China" 323 (323): 1061-1069, 2020

15 Wu Z, "Characteristics of and important lessons from the coronavirus disease 2019(COVID-19)outbreak in China : summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention" 323 (323): 1239-1242, 2020

16 Siddiqi HK, "COVID-19 illness in native and immunosuppressed states : A clinical-therapeutic staging proposal" 39 (39): 405-407, 2020

17 Zheng YY, "COVID-19 and the cardiovascular system" 17 (17): 259-260, 2020

18 Turner AJ, "ACE2 : from vasopeptidase to SARS virus receptor" 25 (25): 291-294, 2004